https://doctransparency.com/doctor/tx/houston/amy-wolford-1013033018
Not Medicare Enrolled

Dr. Amy Wolford, A.P.N

Psychiatric/Mental Health Clinical Nurse Specialist · Houston, TX
Low-engagement
14340 TORREY CHASE BLVD, Houston, TX 77014
2815808086
In practice since 2007 (19 years)
NPI: 1013033018 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wolford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wolford? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wolford

Dr. Amy Wolford is a psychiatric/mental health clinical nurse specialist in Houston, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Wolford received a total of $6,464 from 33 pharmaceutical and/or device companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatric/mental health clinical nurse specialist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wolford is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $6,464 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,464
Total received (2021-2024)
Avg $1,616/year across 4 years
Top 10% in TX for psychiatric/mental health clinical nurse specialist
33
Companies
427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,464 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,947
2023
$1,628
2022
$1,106
2021
$1,782

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc.
$852
Otsuka America Pharmaceutical, Inc.
$698
Teva Pharmaceuticals USA, Inc.
$480
ABBVIE INC.
$410
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$380
Janssen Pharmaceuticals, Inc
$340
Alkermes, Inc.
$297
Neurocrine Biosciences, Inc.
$285
Corium, LLC
$273
AbbVie Inc.
$238
Takeda Pharmaceuticals U.S.A., Inc.
$216
Almatica Pharma LLC
$201
Vanda Pharmaceuticals Inc.
$200
Axsome Therapeutics, Inc.
$199
Sunovion Pharmaceuticals Inc.
$183
Neos Therapeutics, LP
$155
Noven Therapeutics, LLC
$155
Bausch Health US, LLC
$152
Avanir Pharmaceuticals, Inc.
$126
Supernus Pharmaceuticals, Inc.
$81
Lundbeck LLC
$76
JAZZ PHARMACEUTICALS INC.
$75
ACADIA Pharmaceuticals Inc
$68
Ironshore Pharmaceuticals Inc.
$49
Indivior Inc.
$43
Eisai Inc.
$40
Tris Pharma Inc
$37
Avadel CNS Pharmaceuticals, LLC
$33
IRONSHORE PHARMACEUTICALS INC.
$31
IDORSIA PHARMACEUTICALS US INC
$30
E.R. Squibb & Sons, L.L.C.
$25
Corium, Inc.
$21
Alfasigma USA, Inc.
$15
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · CAPLYTA · COBENFY · Cotempla XR-ODT · Dayvigo · FANAPT · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LOREEV XR · LUMRYZ · LYBALVI · NUEDEXTA · NUPLAZID · Nuedexta · ONGENTYS · Onyda XR · PERSERIS · QELBREE · QUVIVIQ · Quillivant · REXULTI · SECUADO · Sunosi · TRINTELLIX · UZEDY · VIIBRYD · VRAYLAR · VYVANSE · XYWAV · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for psychiatric/mental health clinical nurse specialist in TX.

Looking for a psychiatric/mental health clinical nurse specialist in Houston?
Compare psychiatric/mental health clinical nurse specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse psychiatric/mental health clinical nurse specialists nearby

Geographic Context

Psychiatric/Mental Health Clinical Nurse Specialists within 10 mi
9
Per 100K population
0.2
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE NORTHWEST
2.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wolford is a psychiatric/mental health clinical nurse specialist, and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Wolford receive payments from pharmaceutical companies?
Yes. Dr. Wolford received a total of $6,464 from 33 companies across 427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Wolford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →